<code id='6C01DE303D'></code><style id='6C01DE303D'></style>
    • <acronym id='6C01DE303D'></acronym>
      <center id='6C01DE303D'><center id='6C01DE303D'><tfoot id='6C01DE303D'></tfoot></center><abbr id='6C01DE303D'><dir id='6C01DE303D'><tfoot id='6C01DE303D'></tfoot><noframes id='6C01DE303D'>

    • <optgroup id='6C01DE303D'><strike id='6C01DE303D'><sup id='6C01DE303D'></sup></strike><code id='6C01DE303D'></code></optgroup>
        1. <b id='6C01DE303D'><label id='6C01DE303D'><select id='6C01DE303D'><dt id='6C01DE303D'><span id='6C01DE303D'></span></dt></select></label></b><u id='6C01DE303D'></u>
          <i id='6C01DE303D'><strike id='6C01DE303D'><tt id='6C01DE303D'><pre id='6C01DE303D'></pre></tt></strike></i>

          Home / entertainment / explore

          explore


          explore

          author:entertainment    Page View:4937
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In